ARCHIVES

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

Obey Raps Reagan Administration For Blocking Report On Formaldehyde Danger

March 27, 1981

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

March 22, 1985